Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Alan Venook

32PUBLICATIONS

159CO-AUTHORS

PharmacogenomicsMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (32)

Sort by Publication Date:

|Feb 03, 2026

Ending the Controversy Around Pretreatment Dihydropyrimidine Dehydrogenase (DPD/<i>DPYD</i>) Testing Heightens the Controversy Over Appropriate Fluoropyrimidine Dosing.

Daniel L Hertz, Alan P Venook

|Sep 04, 2025

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials.

Marco Maria Germani, Beatrice Borelli, Tadayoshi Hashimoto

|Sep 03, 2025

Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202).

Emily K Bergsland, Susan Geyer, Timothy R Asmis

|Jul 10, 2025

Reducing Fluorouracil Doses in Patients With Partial Dihydropyrimidine Dehydrogenase Deficiency Is a Treatment Safety Strategy, Not a Panacea of Precision Dosing.

Daniel L Hertz, Alan P Venook

|Apr 25, 2025

Associations between early tumor shrinkage/depth of response and survival from the ARCAD database.

Hideaki Bando, Yuriko Takeda, Toshihiro Misumi

|Apr 16, 2025

Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity.

Kai R Trepka, Wesley A Kidder, Than S Kyaw

Pageof 6

Frequent Collaborators

12 joint publications

Heinz-Josef Lenz

11 joint publications

Fang-Shu Ou

8 joint publications

Jeffrey A Meyerhardt

8 joint publications

Eileen O'Reilly

7 joint publications

Richard M Goldberg

6 joint publications

Federico Innocenti

5 joint publications

Katherine Van Loon

5 joint publications

Qian Shi

5 joint publications

Andrew B Nixon

4 joint publications

Erin L Van Blarigan

Frequent Collaborators

12 joint publications

Heinz-Josef Lenz

11 joint publications

Fang-Shu Ou

8 joint publications

Jeffrey A Meyerhardt

8 joint publications

Eileen O'Reilly

Top Related Videos

Minimal Erythema Dose (MED) Testing

Minimal Erythema Dose (MED) Testing

Published on : May 28, 2013

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos

Top Related Videos

Minimal Erythema Dose (MED) Testing

Minimal Erythema Dose (MED) Testing

Published on : May 28, 2013

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos